Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 9Pain 5Neuralgia 5Breast Neoplasms 5Agnosia 4Neoplasms 3Head and Neck Neoplasms 2Chronic Pain 2Visceral Pain 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Seizures 1Pinealoma 1Persistent Postoperative Pain 1Pancreatic Neoplasms 1Pain, Intractable 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Obesity 1Neuroectodermal Tumors, Primitive 1Myotoxicity 1Mouth Neoplasms 1Meningioma 1Medulloblastoma 1Lymphoma, Follicular 1Lymphoma 1Liver Neoplasms 1Leiomyoma 1Inflammation 1Hot Flashes 1

Interventions

Pregabalin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Persistent Postoperative Pain × Pregabalin × Clear all
NCT03216187 2025-10-07

PREVENT

University Hospital, Geneva

Phase 3 Terminated
126 enrolled

Persistent Postoperative Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡